The High Authority for Health (HAS) announced that it would "
update
" Tuesday, March 2, its opinion on the use of the AstraZeneca vaccine for people over 65, who are deprived for the moment while hundreds of thousands of doses have not yet been used.
Read also: The AstraZeneca vaccine would be very effective in the elderly
The HAS "
updates its opinion on the place of the AstraZeneca vaccine in the vaccine strategy, especially on the over 65s
," said the body on Monday, announcing a videoconference for the press on Tuesday at 9:15 am.
The announcement comes after a study from the University of Edinburgh, published last week, tends to confirm the effectiveness of AstraZeneca's vaccine, even in people over 80 years old.
Several health authorities currently recommend this vaccine only to under 65s, believing that there is a lack of data on its effectiveness beyond this age.
After a notice to this effect from the HAS on February 2, the government reserved it for all health professionals, including those under 50, and two million people aged 50 to 64 with comorbidity. .
But many caregivers have shunned this vaccine, especially because of side effects such as strong flu-like symptoms in younger people.
Questions have also emerged about the effectiveness of this vaccine in countering the South African variant of the coronavirus.
Result, in France, only 270,000 doses of this vaccine had been administered Saturday, February 27, while the country received 1.6 million according to a table communicated by the Ministry of Health.
It is the opening since last Thursday of vaccination for 50-64 year olds with comorbidities that has boosted the figures, since the number of injected doses has doubled since the middle of the week, from less than 140,000 to 270,000 .
